Author Showcase
Ambra Villani
Ambra Villani, PhD, is a scientist and science communicator at MaxWell Biosystems. Originally from Italy, she began her international research journey during her master’s studies at the University of Milano-Bicocca, completing her thesis at Yale University. She later earned her PhD at EMBL Heidelberg, where she specialized in developmental biology, microscopy, and molecular biology. As a postdoctoral researcher and senior scientist at the University of Zurich, Ambra developed innovative chimeric models to investigate the behavior of human iPSC-derived microglia in living systems. Her research experience now informs her work communicating complex scientific concepts and advancing conversations around functional cellular models and emerging technologies. A long-standing advocate for accessible, evidence-based science, she also co-founded Facts&Reasons to help counter scientific misinformation. Outside work, Ambra enjoys cooking, spending time with family and friends, and challenging the laws of gravity through acrobatic fitness.
MaxWell Biosystems Celebrates 10 Years of Advancing Neuroscience and Drug Discovery
Nearly 300 guests joined MaxWell Biosystems in Zurich to celebrate ten years of advancing neuroscience and drug discovery. Today, more than 400 systems are installed in some 30 countries.
MaxWell Biosystems and Exobiosphere Partner to Bring High-Content Electrophysiology to Space
MaxWell Biosystems and Exobiosphere announce a partnership to integrate high-content electrophysiology into automated drug screening workflows in microgravity, enabling direct functional readouts from neuronal and cardiac models.
How Can Engineered Neuronal Networks Advance Neurocomputing?
Prof. Hideaki Yamamoto answers audience questions on engineered neuronal networks, reservoir computing, biological versus artificial intelligence, and training living networks.
How Can Human Neural Models Better Support Development and Disease Research?
Experts answer audience questions on human neural models, neurodegenerative disease, spatial transcriptomics, axonal vulnerability, and neuronal function.